Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Dec;183(6):1151-1152.
doi: 10.1111/bjd.19486. Epub 2020 Sep 24.

Negative tests for SARS-CoV-2 infection do not rule out its responsibility for chilblains: reply from the authors

L Le Cleach  1 , S Fourati  2 , E Sbidian  1 , M Beylot-Barry  3
Affiliations
Comment

Negative tests for SARS-CoV-2 infection do not rule out its responsibility for chilblains: reply from the authors

L Le Cleach et al. Br J Dermatol. 2020 Dec.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Battesti G, Descamps V. Negative tests for SARS‐CoV‐2 infection do not rule out its responsibility for chilblains. Br J Dermatol 2020; 183:1168. - PMC - PubMed
    1. Le Cleach L, Dousset L, Assier H et al. Most chilblains observed during the COVID‐19 outbreak occur in patients who are negative for COVID‐19 on polymerase chain reaction and serology testing. Br J Dermatol 2020; 183:866–74. - PMC - PubMed
    1. Battesti G, El Khalifa J, Abdelhedi N et al. New insights in COVID‐19‐associated chilblains: a comparative study with chilblain lupus erythematosus. J Am Acad Dermatol 2020; 83:1219–22. - PMC - PubMed
    1. Hadjadj J, Yatim N, Barnabei L et al. Impaired type I interferon activity and inflammatory responses in severe COVID‐19 patients. Science 2020; 369:718–24. - PMC - PubMed
    1. Trouillet‐Assant S, Viel S, Gaymard A et al. Type I IFN immunoprofiling in COVID‐19 patients. J Allergy Clin Immunol 2020; 146:206–8.e2. - PMC - PubMed